IL17A and lung carcinoma: In lung cancer, IL-17A/F promotes the adoption of an M2-like phenotype by macrophages, which enhances tumor cell migration, proliferation, and angiogenesis, thereby supporting tumor progression (Ferreira et al., 2020).